China Pharma Holdings, Inc.

CPHI

Exchange: NYSE
Industry: Pharmaceutical Preparations
SEC CIK: 0001106644

SEC filings (opens in a new tab)

No open-market purchases or sales by China Pharma Holdings, Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $134.5K in total; no superinvestor holds it.

Q1 2022 vs. Q4 2021

How the institutions holding China Pharma Holdings, Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022 All holders in Q4 2021

13F holders of CPHI: Q4 2021 compared with Q1 2022
Measure	Q4 2021	Q1 2022	Change
Holders	7	10	+3
Shares	879.5K	673.2K	−206.3K (−23.5%)
Value	$423.7K	$262.0K	−$161.7K (−38.2%)

New holders (4)

Institutions that held China Pharma Holdings, Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to CPHI in Q1 2022
Institution	Shares	Value	% of portfolio
Millennium Management LLC	24,063	$9.00K	0.00%
Two Sigma Securities, LLC	13,438	$5.00K	0.00%
UBS Group AG	9,526	$4.00K	0.00%
Joseph P. Lucia & Associates, LLC	9,000	$4.00K	0.00%

Sold out (1)

Institutions that held China Pharma Holdings, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of CPHI in Q1 2022
Institution	Shares, Q4 2021	Value, Q4 2021
Susquehanna International Group, LLP	22,964	$11.0K